Product Program year 2025 Source: CMS Open Payments

Adherus Autospray Et Dural Sealant

Device Craniomaxillofacial

PDI 00897146002025

Open in the dashboard

General payments

$61,728

488 payments

Research payments

$469,240

5 payments

Through program year 2025, $61,728 in general payments and $469,240 in research payments were reported against Adherus Autospray Et Dural Sealant (Craniomaxillofacial).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $14,177 108
2024 General $14,374 122
2024 Research $350,609 3
2023 General $11,698 90
2022 General $18,416 132
2022 Research $118,631 2
2021 General $3,063 36

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $61,728 488 payments
Top recipients General payments · program year 2025
  1. Ochsner Clinic Foundation Teaching hospital · LA $5,000 35% · 4 payments
  2. U Of U Hospitals & Clinics Teaching hospital · UT $3,000 21% · 2 payments
  3. Adam Kaufman Otology & Neurotology · Baltimore, MD $316 2% · 2 payments
  4. Natalie Justicz Otolaryngology · Ann Arbor, MI $316 2% · 2 payments
  5. Thomas Caranasos Thoracic Surgery (Cardiothoracic Vascular Surgery) · Naples, FL $171 1% · 1 payment

The top 5 of 90 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $1,991 38% · 33 practitioners
  2. Otolaryngology $734 14% · 9 practitioners
  3. Otology & Neurotology Otolaryngology $466 9% · 2 practitioners
  4. Physician Assistant $449 9% · 6 practitioners
  5. Nurse Practitioner, Gerontology Nurse Practitioner $214 4% · 2 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Louisiana $5,000 35% · 1 recipient
  2. Utah $3,000 21% · 1 recipient
  3. Florida $2,059 15% · 23 recipients
  4. New York $778 5% · 12 recipients
  5. Missouri $567 4% · 14 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

488 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record